Neurodegenerative diseases, like Alzheimer’s, Parkinson’s, ALS, and Huntington’s Disease, are on the rise worldwide. Yet, there are no effective therapies to cure, prevent, or treat most of these disorders.
To make progress, we launched the Neurodegeneration Challenge Network (NDCN) — bringing together experimental scientists from diverse research fields, along with computational biologists and physicians, to look at this problem across diseases.
Read how this effort is taking shape through the story of Rebecca and Elizabeth — a pair of NDCN researchers working together to treat and prevent rare neurodegenerative diseases that impact children.
Learn more about how the NDCN empowers scientists to pursue bold ideas in order to accelerate the science of neurodegeneration — and ultimately, the path to treatments.
News
Back to allExploring new frontiers in AI-driven biomedical research
CZI and CZ Biohub Network Head of Science Steve Quake shares his insights on how basic science could accelerate discovery.
A day in the life of an early-career researcher: Abbas Rizvi
We sat down with Abbas Rizvi, an associate research scientist at Columbia’s Zuckerman Institute, to explore what a day in the life of an early-career...
Frogs, genes, and cellular antennae: Unlocking the biology of autism
Using frogs as a model organism, CZ Biohub SF Investigator Helen Willsey is revealing surprising connections between autism and hair-like structures on the...
Stay up-to-date on the latest news, publications, competitions, and stories from CZ Biohub.
Cookies and JavaScript are required to access this form.